Wang F, Wang Y, Ren C, Li X, et al. Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma. Pancreatology 2023 Dec 31:S1424-3903(23)01882-3. doi: 10.1016/j.pan.2023.
PMID: 38195328